BridgeMD
New treatment option for Generalized Anxiety
Official title Optimization of Imagery Rescripting Research Using Generative Artificial Intelligence
ClinicalTrials.gov ID: NCT07189715
What this study is testing
- What it's testing
- This pilot randomized controlled trial will investigate the feasibility and effectiveness of using generative artificial intelligence to create personalized therapeutic scripts for imagery rescripting (ImRs). Eighty participants will listen to autobiographical scenarios based on their own memories of childhood criticism and neutral events.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35
You may be able to join if
- Age 18-35
- Score ≥ 8 on GAD-7 (Plummer et al., 2016)
- Ability to recall at least two childhood memories involving parental criticism
You likely can't join if
- History of prolonged physical or sexual abuse
- Current psychotherapy or psychopharmacology
- PTSD diagnosis (DSM-5 screening)
- Substance abuse (TAPS tool)
The study team makes the final eligibility decision.
Where it's taking place
- Poznan, Wielkopolska, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Poznan, Wielkopolska, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.